China Biologic Products Holdings Stock Price and Value Analysis

Should you buy China Biologic Products Holdings stock? (NasdaqGS:CBPO). Let's see how it does in our automated value investing analysis system.

  • This company is making money at a decent rate.
  • This company has fluctuating growth.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company pays no dividend.

Inside the CBPO Numbers

CBPO Price
(China Biologic Products Holdings stock price per share)
[?] CBPO Fair Price
(based on intrinsic value)
[?] CBPO Safety Price (based on a variable margin of safety) $19.19
[?] PE Ratio versus Sector 77% higher than other Healthcare stocks
[?] PE Ratio versus Industry 37% lower than other Biotechnology stocks
[?] Cash Yield 18.82%
[?] Free Cash Flow Jitter 25%

Is China Biologic Products Holdings Stock on Sale?

We believe that China Biologic Products Holdings may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

China Biologic Products Holdings looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy CBPO Stock?

Does China Biologic Products Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.